|
Q4 FY2026
As of Jun 30, 2026
|
Q3 FY2026
As of Mar 31, 2026
|
Q2 FY2026
As of Dec 31, 2025
|
Q1 FY2026
As of Sep 30, 2025
|
Q4 FY2025
As of Jun 30, 2025
|
Q3 FY2025
As of Mar 31, 2025
|
Q2 FY2025
As of Dec 31, 2024
|
Q1 FY2025
As of Sep 30, 2024
|
Q4 FY2024
As of Jun 30, 2024
|
Q3 FY2024
As of Mar 31, 2024
|
Q2 FY2024
As of Dec 31, 2023
|
Q1 FY2024
As of Sep 30, 2023
|
Q4 FY2023
As of Jun 30, 2023
|
Q3 FY2023
As of Mar 31, 2023
|
Q2 FY2023
As of Dec 31, 2022
|
Q1 FY2023
As of Sep 30, 2022
|
Q4 FY2022
As of Jun 30, 2022
|
Q3 FY2022
As of Mar 31, 2022
|
Q2 FY2022
As of Dec 31, 2021
|
Q1 FY2022
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Receivables from managed funds | ||||||||||||||||||||
| Investments in marketable securities | ||||||||||||||||||||
| Investments, at fair value | ||||||||||||||||||||
| Total investments, at fair value | ||||||||||||||||||||
| Prepaid and other current assets | ||||||||||||||||||||
| Real estate under development | ||||||||||||||||||||
| Real estate assets, net | ||||||||||||||||||||
| Related party loan receivable | ||||||||||||||||||||
| Assets of Consolidated Funds - Cash and cash equivalents | ||||||||||||||||||||
| Assets of Consolidated Funds - Investments, at fair value | ||||||||||||||||||||
| Assets of Consolidated Funds - Other assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Identifiable intangible assets, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Right-of-use asset | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES, NON-CONTROLLING INTEREST AND STOCKHOLDERS' EQUITY | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Nonrelated Party | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Payable for securities purchased | ||||||||||||||||||||
| Accrued expenses and other current liabilities | ||||||||||||||||||||
| Total accrued expenses and other current liabilities | ||||||||||||||||||||
| Current portion of lease liabilities | ||||||||||||||||||||
| Liabilities of Consolidated Funds - Payable for securities purchased | ||||||||||||||||||||
| Liabilities of Consolidated Fund - accrued expenses and other | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Lease liabilities, net of current portion | ||||||||||||||||||||
| Long-term debt (face value $26,945) | ||||||||||||||||||||
| Related party payables, net of current portion | ||||||||||||||||||||
| Convertible notes (face value $36,838 and $35,063, including $17,853 and $16,993 held by related parties, respectively) | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders' equity | ||||||||||||||||||||
| Common stock, $0.001 par value; 350,000,000 shares authorized and 31,139,625 shares issued and 29,778,239 outstanding at June 30, 2026; and 27,630,305 shares issued and 26,552,948 outstanding at June 30, 2025 | ||||||||||||||||||||
| Additional paid-in-capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total Great Elm Group, Inc. stockholders' equity | ||||||||||||||||||||
| Redeemable non-controlling interest in Consolidated Funds | ||||||||||||||||||||
| Total stockholders' equity | ||||||||||||||||||||
| Total liabilities and stockholders' equity | ||||||||||||||||||||
Loading...